AC, C., S, V., JM, W., & DA, H. (2013). Ocular surface tolerability of prostaglandin analogs and prostamides in patients with glaucoma or ocular hypertension. Advances in therapy, 30(3), 260. https://doi.org/10.1007/s12325-013-0014-7
Chicago Style (17th ed.) CitationAC, Crichton, Vold S, Williams JM, and Hollander DA. "Ocular Surface Tolerability of Prostaglandin Analogs and Prostamides in Patients with Glaucoma or Ocular Hypertension." Advances in Therapy 30, no. 3 (2013): 260. https://doi.org/10.1007/s12325-013-0014-7.
MLA (9th ed.) CitationAC, Crichton, et al. "Ocular Surface Tolerability of Prostaglandin Analogs and Prostamides in Patients with Glaucoma or Ocular Hypertension." Advances in Therapy, vol. 30, no. 3, 2013, p. 260, https://doi.org/10.1007/s12325-013-0014-7.